Adeka Corporation
Notice of Completion of Share Buyback | June 2026
Takeda Pharmaceutical Company Limited announced that it completed the purchase of 395,000 shares of treasury stock (total amount of 1,614,366,000 yen) from August 2025 to May 2026, bringing the total acquired shares to 4,823,900 shares (total amount of 179,999,366,600 yen).
Key Figures
- Total shares of treasury stock acquired: 4,823,900 shares
- Total purchase price: 17,999,936,600 yen
- Acquisition period: August 12, 2025 – May 29, 2026
AI要約
Overview of Capital Policy
Takeda Pharmaceutical Company Limited conducted share buybacks from August 2025 to May 2026, acquiring a total of 395,000 shares for approximately 1.61 billion yen through open market purchases. As a result, the total acquired treasury stock reached 4,823,900 shares, and the share repurchase was completed within the acquisition period. The maximum number of shares to be repurchased in August 2025 was 10,000,000 shares (9.8% of issued shares), with the method of purchase being market transactions based on a discretionary trading agreement.
Impact on Shareholders and Future Outlook
With the completion of this share buyback, the company has fulfilled its capital policy aimed at enhancing shareholder value and preventing dilution of shares. Going forward, the company plans to continue shareholder returns and improve capital efficiency, with share cancellation scheduled once the designated date is decided. As part of its capital policy, the company will manage its shares appropriately and aim to maximize shareholder interests.
Takeda Pharmaceutical Company Limited
Company overview · Stock price · Financial data · All IR
